Published in Medical Letter on the CDC and FDA, May 23rd, 2010
"The hypothesis was tested that significantly augmented inflammatory markers distinguish VAP from conditions closely mimicking VAP. A prospective, observational cohort study was carried out in two university hospital intensive care units recruiting 73 patients with clinically suspected VAP, and a semi-urban primary care...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.